Support 100 years of independent journalism.

  1. Science & Tech
  2. Coronavirus
14 May 2020updated 06 Oct 2020 9:45am

Pharmaceutical boss causes outrage by saying US has “right“ to receive firm’s coronavirus vaccine first

By Samuel Horti

The boss of a major French pharmaceutical firm has caused uproar by saying the US has the “right” to the largest pre-orders of the company’s coronavirus vaccine because the country is part-funding the research.

Paul Hudson, chief executive of Sanofi, told Bloomberg News: “The US government has the right to the largest pre-order because it’s invested in taking the risk. That’s how it will be because they’ve invested to try and protect their population, to restart their economy. I’ve been campaigning in Europe to say the US will get vaccines first.”

Sanofi, which has partnered with British firm GlaxoSmithKline, has not yet begun trials of its vaccine, which will be ready in late 2021 at the earliest.

France’s higher education minister Frédérique Vidal said Sanofi’s plan was “incomprehensible and disgraceful”, and that a vaccine must be a “public good for the world”. Other critics pointed out that the Paris-based company has received tens of millions of euros in research credits from the French government in recent years.

Select and enter your email address Quick and essential guide to domestic and global politics from the New Statesman's politics team. A weekly newsletter helping you fit together the pieces of the global economic slowdown. The New Statesman’s global affairs newsletter, every Monday and Friday. The best of the New Statesman, delivered to your inbox every weekday morning. The New Statesman’s weekly environment email on the politics, business and culture of the climate and nature crises - in your inbox every Thursday. Our weekly culture newsletter – from books and art to pop culture and memes – sent every Friday. A weekly round-up of some of the best articles featured in the most recent issue of the New Statesman, sent each Saturday. A newsletter showcasing the finest writing from the ideas section and the NS archive, covering political ideas, philosophy, criticism and intellectual history - sent every Wednesday. Sign up to receive information regarding NS events, subscription offers & product updates.
  • Administration / Office
  • Arts and Culture
  • Board Member
  • Business / Corporate Services
  • Client / Customer Services
  • Communications
  • Construction, Works, Engineering
  • Education, Curriculum and Teaching
  • Environment, Conservation and NRM
  • Facility / Grounds Management and Maintenance
  • Finance Management
  • Health - Medical and Nursing Management
  • HR, Training and Organisational Development
  • Information and Communications Technology
  • Information Services, Statistics, Records, Archives
  • Infrastructure Management - Transport, Utilities
  • Legal Officers and Practitioners
  • Librarians and Library Management
  • Management
  • Marketing
  • OH&S, Risk Management
  • Operations Management
  • Planning, Policy, Strategy
  • Printing, Design, Publishing, Web
  • Projects, Programs and Advisors
  • Property, Assets and Fleet Management
  • Public Relations and Media
  • Purchasing and Procurement
  • Quality Management
  • Science and Technical Research and Development
  • Security and Law Enforcement
  • Service Delivery
  • Sport and Recreation
  • Travel, Accommodation, Tourism
  • Wellbeing, Community / Social Services
I consent to New Statesman Media Group collecting my details provided via this form in accordance with the Privacy Policy

Olivier Bogillot, the head of Sanofi’s French division, distanced himself from Hudson’s comments today, saying the vaccine would reach the US, France and Europe “at the same time”.

Last month, the United Nations set up a task force to ensure any vaccine was evenly distributed around the world.